Andrew Spaventa, the Chief Executive Officer of Singular Genomics Systems , Inc. (NASDAQ:OMIC), recently sold 800 shares of the company's common stock, totaling $15,912. The shares were sold at an ...
Singular Genomics Systems, Inc. (market cap: $50.32M), a company specializing in laboratory analytical instruments, has voluntarily amended its proxy statement following two lawsuits alleging ...
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Singular Genomics Systems, Inc. ("Singular Genomics" or "the ...
LOS ANGELES, CA / ACCESS Newswire / January 23, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Singular ...
Singular Genomics Systems, Inc. (market cap: $50.32M), a company specializing in laboratory analytical instruments, has voluntarily amended its proxy statement following two lawsuits alleging ...
The investigation focuses on determining if the Singular Genomics board breached its fiduciary duties to shareholders. Singular Genomics announced on December 23, 2024, that it "has entered into ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback